UdeM’s Biopharmaceutical Unit: playing a key role in drug development
While the COVID-19 pandemic caused slowdowns in many fields, it underscored the importance of UdeM’s drug discovery units.
While the COVID-19 pandemic caused slowdowns in many fields, it underscored the importance of UdeM’s drug discovery units.
At the second edition of the IRIC’s Rendez-vous Audace conference, Yoshua Bengio and Sébastien Lemieux explain how artificial intelligence is being used to advance cancer research.
The head of UdeM’s chemistry department thinks this nation can produce enough of its own prescription medications and not have to rely on imports in the fight against COVID-19.
The Quebec government has awarded Université de Montréal $13 million to support the creation of Médicament Québec, an initiative that aims to revitalize the province’s pharmaceutical industry.